Mild cognitive dysfunction does not affect diabetes mellitus control in minority elderly adults

J Am Geriatr Soc. 2014 Dec;62(12):2363-8. doi: 10.1111/jgs.13129. Epub 2014 Nov 29.

Abstract

Objectives: To determine whether older adults with type 2 diabetes mellitus and cognitive dysfunction have poorer metabolic control of glycosylated hemoglobin, systolic blood pressure, and low-density lipoprotein cholesterol than those without cognitive dysfunction.

Design: Prospective cohort study.

Setting: A minority cohort in New York City previously recruited for a trial of telemedicine.

Participants: Persons aged 73.0 ± 3.0 (N = 613; 69.5% female; 82.5% Hispanic, 15.5% non-Hispanic black).

Measurements: Participants were classified with executive or memory dysfunction based on standardized score cutoffs (<16th percentile) for the Color Trails Test and Selective Reminding Test. Linear mixed models were used to compare repeated measures of the metabolic measures and evaluate the rates of change in individuals with and without dysfunction.

Results: Of the 613 participants, 331 (54%) had executive dysfunction, 202 (33%) had memory dysfunction, and 96 (16%) had both. Over a median of 2 years, participants with executive or memory dysfunction did not exhibit significantly poorer metabolic control than those without executive function or memory type cognitive dysfunction.

Conclusion: Cognitive dysfunction in the mild range did not seem to affect diabetes mellitus control parameters in this multiethnic cohort of older adults with diabetes mellitus, although it cannot be excluded that cognitive impairment was overcome through assistance from formal or informal caregivers. It is possible that more-severe cognitive dysfunction could affect control.

Trial registration: ClinicalTrials.gov NCT00271739.

Keywords: cognition; control; diabetes mellitus; elderly.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • Biomarkers / blood
  • Cholesterol, LDL / blood*
  • Cognitive Dysfunction / blood*
  • Cognitive Dysfunction / epidemiology
  • Cognitive Dysfunction / ethnology
  • Demography
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / epidemiology
  • Diabetes Mellitus, Type 2 / ethnology
  • Executive Function*
  • Female
  • Glycated Hemoglobin / metabolism*
  • Humans
  • Male
  • Memory Disorders / blood*
  • Memory Disorders / epidemiology
  • Memory Disorders / ethnology
  • Neuropsychological Tests
  • New York City / epidemiology
  • Prospective Studies
  • Risk Factors
  • Telemedicine

Substances

  • Biomarkers
  • Cholesterol, LDL
  • Glycated Hemoglobin A

Associated data

  • ClinicalTrials.gov/NCT00271739